TENT5A Increases Glioma Malignancy and Promotes its Progression.

Jiali HuLei ZengRonghuan HuDan GongMengmeng LiuJianwu Ding
Published in: Recent patents on anti-cancer drug discovery (2024)
Our data showed that the expression of TENT5A is associated with the pathological grade of glioma. Knockdown of TENT5A decreased the ability of proliferation, invasion and migration of glioma cells. High levels of TENT5A in glioma cells are lethal. Therefore, TENT5A could be a new target for glioma treatment.